Sign inJoin waitlistJoin the waitlist

FC

Filipe De Carvalho

Physician · Dana-Farber Cancer Institute

Credentials: · · · ·

History

Dana-Farber Cancer Institute · Brigham and Women's Hospital
2021–Present

Urology
Brigham and Women's Hospital
2020–2022
Urology
MedStar Health Georgetown University
2015–2020
MedStar Georgetown University Hospital
2015–2016
Doctor of Medicine
2003–2007

Research

Formation of toxic oligomeric alpha-synuclein species in living cells
PLoS ONE · 2008 · 341 citations
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
Modern Pathology · 2015 · Co-first of 12 authors · 120 citations
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Cell Reports · 2022 · 107 citations

Kent Mouw
12 papers
Matthew Mossanen
12 papers
Adam Kibel
9 papers
Eli Van Allen
8 papers
Mark Preston
8 papers
AF
Adam Feldman
7 papers
Joaquim Bellmunt
7 papers
Lambros Stamatakis
7 papers
Michelle Hirsch
7 papers
David Berman
5 papers
JK
Jillian Kelly
5 papers · 4 as a resident
Keith Kowalczyk
5 papers

Grants

Tumor-Immune Interactions and Cisplatin Resistance in Bladder Cancer
National Cancer Institute · K08
Contact PI · $632.9K · Brigham and Women's Hospital
2024–2029

Clinical trials

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2028